Thursday, March 6, 2008

RIL - new pharma unit in Jamnagar

Reliance Life Sciences (RLS) plans to create a pharma unit in Jamnagar

The aim is to set up a facility for Active pharmaceutical ingredients (API) and formulations manufacturing complex at Jamnagar, to benefit from tax brackets the complex will be constructed in the multi-product special economic zone (SEZ) established by Reliance Industries (RIL).
Area of investments will be medical, plant and industrial biotechnology, bio-pharmaceutical products especially blood pharma proteins, bio-generic recombinant proteins, humanized monoclonal antibodies and si-RNA molecules will be main products of the facility.
bio-pharmaceutical products such as albumin, fibrin sealants and immunoglobulin, anti-hemophiliac factor, virus inactivated plasma will be marketed under Reliance brand.
RIL is planning to have one unit each for Contract Research Organization (CRO) and Reliance Clinical Research Services (RCRS).

With this new units RIL will have its upper hand in Clinical Research as well.